Investment House LLC Sells 10,539 Shares of Stryker Corporation $SYK

Investment House LLC lessened its holdings in Stryker Corporation (NYSE:SYK) by 26.7% in the third quarter, according to its most recent filing with the SEC. The institutional investor owned 28,953 shares of the medical technology company’s stock after selling 10,539 shares during the period. Investment House LLC’s holdings in Stryker were worth $7,973,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in SYK. Gables Capital Management Inc. bought a new position in Stryker in the 2nd quarter worth approximately $25,000. Kilter Group LLC purchased a new stake in Stryker during the 2nd quarter valued at approximately $25,000. Highland Investment Advisors LLC bought a new stake in shares of Stryker during the second quarter valued at approximately $25,000. Cornerstone Financial Management LLC raised its position in shares of Stryker by 66.0% during the second quarter. Cornerstone Financial Management LLC now owns 78 shares of the medical technology company’s stock valued at $25,000 after buying an additional 31 shares during the last quarter. Finally, Compass Financial Management LLC purchased a new position in shares of Stryker in the second quarter worth $27,000. Institutional investors own 77.09% of the company’s stock.

Analyst Ratings Changes

A number of equities analysts recently weighed in on the stock. Argus set a $370.00 target price on shares of Stryker in a research report on Thursday, July 9th. Stifel Nicolaus decreased their price target on shares of Stryker from $360.00 to $330.00 and set a “buy” rating on the stock in a research note on Wednesday, September 30th. Piper Sandler dropped their price objective on shares of Stryker from $420.00 to $390.00 and set an “overweight” rating for the company in a report on Friday, July 31st. Canaccord Genuity Group cut their price objective on Stryker from $400.00 to $385.00 and set a “buy” rating for the company in a research report on Friday, September 18th. Finally, JPMorgan Chase & Co. cut their price objective on Stryker from $400.00 to $350.00 and set an “overweight” rating for the company in a research report on Friday, July 31st. One equities research analyst has rated the stock with a Strong Buy rating, seventeen have given a Buy rating and six have issued a Hold rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $369.00.

Stryker Price Performance

SYK stock opened at $307.41 on Friday. Stryker Corporation has a 52 week low of $267.00 and a 52 week high of $389.33. The company has a quick ratio of 1.33, a current ratio of 2.16 and a debt-to-equity ratio of 0.59. The company has a fifty day simple moving average of $295.86 and a two-hundred day simple moving average of $311.96. The firm has a market capitalization of $117.91 billion, a P/E ratio of 31.86, a price-to-earnings-growth ratio of 1.92 and a beta of 0.78.

Stryker (NYSE:SYK) last issued its quarterly earnings data on Thursday, July 30th. The medical technology company reported $3.69 EPS for the quarter, topping analysts’ consensus estimates of $3.49 by $0.20. Stryker had a net margin of 14.43% and a return on equity of 23.63%. The business had revenue of $6.59 billion during the quarter, compared to analysts’ expectations of $6.58 billion. During the same period last year, the company posted $3.13 EPS. The business’s revenue was up 9.4% on a year-over-year basis. Stryker has set its FY 2026 guidance at 14.950-15.100 EPS. Analysts anticipate that Stryker Corporation will post 14.93 earnings per share for the current fiscal year.

Stryker Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 30th. Shareholders of record on Wednesday, September 30th will be paid a dividend of $0.88 per share. This represents a $3.52 annualized dividend and a yield of 1.1%. The ex-dividend date of this dividend is Wednesday, September 30th. Stryker’s payout ratio is presently 36.48%.

Insiders Place Their Bets

In other Stryker news, insider Debra King sold 826 shares of the company’s stock in a transaction that occurred on Tuesday, August 18th. The stock was sold at an average price of $336.30, for a total transaction of $277,783.80. Following the sale, the insider directly owned 6,210 shares in the company, valued at $2,088,423. This represents a 11.74% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this link. Also, Director Ronda Stryker sold 50,000 shares of Stryker stock in a transaction that occurred on Wednesday, August 19th. The stock was sold at an average price of $340.10, for a total value of $17,005,000.00. Following the completion of the transaction, the director owned 2,251,375 shares of the company’s stock, valued at approximately $765,692,637.50. This trade represents a 2.17% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold 351,267 shares of company stock valued at $118,197,701 over the last ninety days. 4.60% of the stock is owned by insiders.

Stryker Profile

Stryker Corporation (NYSE: SYK) is a global medical technology company that develops and manufactures products used by healthcare providers in hospitals, surgical centers and other clinical settings. Its offerings are designed to support orthopaedic procedures, surgery, emergency care, neurovascular treatment and patient handling.

The company’s product portfolio includes orthopaedic implants and instruments, products for trauma and spine procedures, surgical equipment, endoscopy systems, patient beds and stretchers, emergency medical equipment, and neurovascular devices used in the treatment of conditions such as stroke.